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Abstract
Background: The phosphatase chronophin (CIN/PDXP) has been shown to be an important regulator of glioma
cell migration and invasion. It has two known substrates: p-Ser3-cofilin, the phosphorylated form of the actin
binding protein cofilin, and pyridoxal 5′-phosphate, the active form of vitamin B6. Phosphoregulation of cofilin,
among other functions, plays an important role in cell migration, whereas active vitamin B6 is a cofactor for more
than one hundred enzymatic reactions. The role of CIN has yet only been examined in glioblastoma cell line
models derived under serum culture conditions.
Results: We found that CIN is highly expressed in cells cultured under non-adherent, serum-free conditions that are
thought to better mimic the in vivo situation. Furthermore, the substrates of CIN, p-Ser3-cofilin and active vitamin
B6, were significantly reduced as compared to cell lines cultured in serum-containing medium. To further examine
its molecular role we stably knocked down the CIN protein with two different shRNA hairpins in the glioblastoma
cell lines NCH421k and NCH644. Both cell lines did not show any significant alterations in proliferation but
expression of differentiation markers (such as GFAP or TUBB3) was increased in the knockdown cell lines. In
addition, colony formation was significantly impaired in NCH644. Of note, in both cell lines CIN knockdown
increased active vitamin B6 levels with vitamin B6 being known to be important for S-adenosylmethionine
biosynthesis. Nevertheless, global histone and DNA methylation remained unaltered as was chemoresistance
towards temozolomide. To further elucidate the role of phosphocofilin in glioblastoma cells we applied inhibitors
for ROCK1/2 and LIMK1/2 to our model. LIMK- and ROCK-inhibitor treatment alone was not toxic for glioblastoma
cells. However, it had profound, but antagonistic effects in NCH421k and NCH644 under chemotherapy.
Conclusion: In non-adherent glioblastoma cell lines cultured in serum-free medium, chronophin knockdown
induces phenotypic changes, e.g. in colony formation and transcription, but these are highly dependent on the
cellular background. The same is true for phenotypes observed after treatment with inhibitors for kinases regulating
cofilin phosphorylation (ROCKs and LIMKs). Targeting the cofilin phosphorylation pathway might therefore not be a
straightforward therapeutic option in glioblastoma.
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Background
Gliomas, the most common type of primary brain
tumor, diffusely infiltrate the adjacent brain tissue mak-
ing complete surgical resection impossible [1]. The pro-
tein cofilin, a crucial regulator of actin dynamics, has
been found to be a key regulator of migration and inva-
sion in many types of cancer [2] including gliomas [3].
Active cofilin both supplies new barbed ends for actin
polymerization [4] and promotes turnover of actin fila-
ments [5]. The activity of cofilin is regulated by phos-
phorylation on a single serine residue, serine-3, which
prevents its binding to actin filaments [6]. Upregulation
of LIM-kinases that phosphorylate cofilin has been
shown to lead to increased invasion in several types of
cancer [7]. The pathway regulating cofilin phosphoryl-
ation is dysregulated in gliomas as compared to normal
brain tissue in favor of an increased phosphorylation of
cofilin [8].
It has been shown that proteins regulating cofilin
phosphorylation, e.g. LIMKs and RHOC, are important
regulators of pluripotency [9] and stemness in cancer
cells [10]. This motivated us to examine the role of the
cofilin phosphatase chronophin (CIN/PDXP) [11] in gli-
oma cells cultured under non-adherent, serum-free con-
ditions. These cells were derived under stem cell-
permissive conditions [12] and are thought to better
mimick the situation in the patient [13]. Of note, serum-
cultured glioma cells deficient of CIN have a reduced
capacity to grow in vivo [8] suggesting a loss of stemness
after CIN reduction.
As CIN was initially described to dephosphorylate pyri-
doxal 5′-phosphate, the active form of vitamin B6 [14], we
also examined the effects of CIN on this metabolite. Vita-
min B6 is a cofactor in a multitude of enzymatic reactions
[15] and regulates synthesis of S-adenosylmethionine
(SAM). SAM levels and DNA-methylation as well as his-
tone methylation are intimately linked with SAM being
the main methyl donor for methylation reactions by
DNA- and histone methylases [16]. Therefore, we hypoth-
esized that CIN might be able to regulate stemness via al-
terations in cofilin phosphorylation or by altering the
epigenome of the glioma initiating cells (by inducing glo-
bal hypermethylation). Indeed, a subset of preferentially
proneural and IDH-mutated gliomas shows a global
hypermethylator phenotype [17]. However, as not all gli-
omas that show global hypermethylation carry IDH-muta-
tions, CIN downregulation might be an alternative
mechanism inducing a global shift in methylation patterns
[18]. It should be noted that although CIN is downregu-
lated in the tumor bulk in glioblastomas [8] tumor initiat-
ing cells may be a rare population in glioblastomas [19].
The estimated frequencies vary widely from well below 1%
[19] up to ~ 10–30% [13, 19] depending on the assay used
for quantification. Therefore a role of CIN in regulation of
cell growth or stemness does not contradict its downregu-
lation in the tumor bulk.
Both regulation of cofilin phosphorylation [20] as well
as vitamin B6 [21] have been implicated in modulation
of chemoresistance. Inhibitors for LIM-Kinases and
ROCK (Rho-associated protein kinase), regulating cofilin
phosphorylation [4], are readily available. We therefore
also explored the potential to modulate chemoresistance




We used five adherent glioblastoma cell lines cultured in
serum: T98G, TP365, U87, U251, A172. T98G (#CRL-
1690), U87 (#HTB-14) and A172 (#CRL-1620) were
from ATCC (Manassas, VA, USA). TP365 and U251
were kindly provided by Prof. V. P. Collins, Cambridge,
UK. Identity of all cell lines was confirmed by short tan-
dem repeat analysis. The cells were cultured in complete
medium consisting of high glucose (4.5 g/L) Dulbecco’s
modified Eagle’s medium with stable glutamine (PAN
Biotech, Aidenbach, Germany) supplemented with
100 U/ml penicillin, 100 μg/ml streptomycin (GIBCO)
and 10% fetal bovine serum (PAN Biotech). Five previ-
ously characterized [12] human primary stem-like glio-
blastoma cell lines (NCH1425, NCH421k, NCH465,
NCH601, NCH644, all supplied by Prof. Christel
Herold-Mende, Heidelberg, Germany) were cultured in
DMEM/Ham’s F-12 medium with stable glutamine sup-
plemented with 100 U/ml penicillin, 100 μg/ml strepto-
mycin, 20% BIT admixture supplement (Pelo Biotech,
Planegg, Germany), 20 ng/ml epidermal growth factor
(EGF) (ReliaTech, Wolfenbuettel, Germany) and
20 ng/ml basic fibroblast growth factor 2 (bFGF2)
(ReliaTech). Cells were handled under aseptic condi-
tions and grown at 37 °C and 5% CO2. All cells were
tested for mycoplasma contamination.
Establishment of stable shRNA cell lines
Plasmids coding for different validated CIN targeting
shRNAs in a pLKO.1-puro backbone (TRCN0000050044,
TRCN0000050046) and the SHC002 plasmid, a control
shRNA (Sigma-Aldrich, St. Louis, USA), were transfected
in HEK293T cells with lipofectamine 2000 (Life Technolo-
gies) together with a third generation lentiviral packaging
system (Addgene, Cambridge, MA, USA) and the p-
advantage vector (Promega, Fitchburg, WI, USA). 72 h
and 96 h after transfection, supernatants were harvested
and remaining cells were removed from the solution by
centrifugation for 5 min at 100 x g. To remove any serum
remnant from the HEK293T cell medium, which would
induce differentiation of the stem-like cells, we purified
the lentiviral particles twice with PEGit (System
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Biosciences, Palo Alto, CA, USA) according to the manu-
facturer’s instructions. Briefly, for one round of purifica-
tion, 4 parts supernatant were mixed with 1 part PEGit,
and the solution was incubated O/N at 4 °C. Viral parti-
cles were collected by centrifugation at 1500 x g, for
30 min at 4 °C. The supernatant was discarded and the
remaining pellet and liquid recentrifuged for 5 min and
1500 x g at 4 °C. After complete removal of the super-
natant, the remaining pellet was dissolved in 4.5 ml
DMEM/F12 for further purification or transduction of
stem-like cells. We determined the concentration of the
lentiviral particles with a p24 ELISA kit (Cellbiolabs, San
Diego, CA, USA) and infected the cells at an MOI of 5.
Two days after transduction 1 μg/ml puromycin (Sigma-
Aldrich, St. Louis, USA) was added to the culture medium
to select for shRNA expressing cells. After two weeks of
selection we obtained robustly proliferating cell cultures.
For simplicity, TRCN0000050044 is hereafter referred to
as CIN shRNA #1, TRCN0000050046 as CIN shRNA #2
and SHC002 as CTRL.
Proliferation, chemosensitivity and cell viability assay
For proliferation assays, 2000 stably transduced NCH421k
and NCH644 cells were seeded in five separate 96-well
plates in a final volume of 100 μl. Every day, 10 μl resa-
zurin (R&D Systems, Minneapolis, MN, USA) were added
to one plate, incubation was performed for 3 h at 37 °C
and 5% CO2 and fluorescence intensity was measured at
in a FLUOstar Omega microplate reader at Ex544nm/
Em590nm (BMG Labtech, Ortenberg, Germany). After
background (medium w/o cells plus resazurin) substrac-
tion the values were expressed as fold of the intensity at
day 1. The chemotherapeutic agent temozolomide
(Sigma-Aldrich) was dissolved in DMSO at concentrations
of 200 mM. The ROCK-inhibitors Y-27632 (Sigma-Al-
drich) and fasudil (Tocris Bioscience, Bristol, UK) were
dissolved in sterile ultrapure water (Carl-Roth, Karlsruhe,
Germany) at a concentration of 10 mM. The LIMK-
inhibitor LIMKi3 (Tocris Bioscience) was dissolved in
DMSO at a concentration of 10 mM. All reagents were
thawed three times at maximum. For chemosensitivity as-
says, 1000 NCH644 or NCH421k cells were seeded per
well on a 96-well plate in stem cell medium. The cells
were treated with 10 serial dilutions of temozolomide ran-
ging from final concentrations of 1000 to 0.01 μM. Then,
Y-27632, fasudil or LIMKi3 were added in a final concen-
tration of 10 μM (in a final volume of 200 μl), a concentra-
tion chosen based on literature reports [22–24]. DMSO
and water served as a control. The plates were incubated
for 96 h, 20 μl of resazurin were added and measurement
of resazurin fluorescence intensity was performed as has
been described above. For the chemosensitivity assays of
shRNA cells the protocol was performed without the in-
hibitor treatement.
(PhosTag) western blotting
For western blot cells were washed in DPBS supple-
mented with 1% BSA and lysed in 150 μl of RIPA
lysis buffer with added phosphatase and protease in-
hibitor cocktail (Roche, Basel, Switzerland) and kept
on ice. The lysates were mixed with Laemmli buffer,
denatured at 90 °C for 5 min. DNA was sheared with
a 20G × 1.5″ needle and the samples were run on 8–
15% SDS-PAGE gels depending on the size of the an-
alyzed protein. MagicMark™ Western Protein Standard
(Life Technologies) or Color Prestained Protein
Standard, Broad Range (NEB, Ipswich, MA, USA)
were used as a molecular weight marker. Gels were
run at a constant voltage of 80 V for 30 min (stack-
ing gel) followed by 140 V for 60–70 min (separating
gel), dependent on the polyacrylamide concentration
of the gels. For separation of cofilin and phosphocofi-
lin PhosTag was added to the gels as has been de-
scribed previously [8]. Protein was blotted from the
SDS-PAGE gels on 0.45 μm nitrocellulose membranes
(Bio-Rad, Munich, Germany) with a semi-dry Fastblot
B44 (Biometra, Goettingen, Germany). Afterwards, the
membrane was blocked using 5% non-fat dry milk for
1 h followed by incubation in primary antibody over
night at 4 °C. The primary antibodies were diluted 1:
10,000 (Tubulin, mouse antibody [Clone DM1A],
Sigma-Aldrich) or 1:1000 for CIN (rabbit antibody
[clone C85E3], Cell Signaling Technologies, Danvers,
CO, USA), p-Ser3-cofilin (rabbit antibody [clone
77G2], Cell Signaling Technologies) and cofilin (rabbit
antibody [clone D3F9], Cell Signaling Technologies).
The next day, the membrane was washed three times
in TBS-T for 2 min and then the primary antibody
was detected by anti-rabbit or anti-mouse IgG linked
to horseradish peroxidase (Santa Cruz, Dallas, Texas,
USA) diluted 1:10,000 in a solution containing 5%
non-fat dry milk for 1.5 h at RT. Picoluminescence
substrate (Thermo Fisher Scientific, Waltham, Massa-
chusetts, USA) was used for development on a
LAS4000 imaging system (GE healthcare, Munich,
Germany). Quantification was performed with Image-
Quant TL ver. 7.0 (GE healthcare).
RNA / DNA isolation and cDNA synthesis
RNA and DNA were isolated with the RNA/DNA All-
prep kit (Qiagen, Hilden, Germany) according to the
manufacturer’s instructions. cDNA synthesis was per-
formed from 1 μg total RNA using random hexamer
primers (Gene Link, Hawthorne, NY, USA) and the
SuperScript™ II Reverse Transcriptase (Life Technolo-
gies). RNA from normal human astrocytes was commer-
cially available (ScienCell Research laboratories, Corte
Del CedroCarlsbad, CA).
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Real-time (RT-)PCR
Real-time RT-PCR was performed with the SensiFAST™
SYBR Hi-Rox Kit (Bioline, London, UK) on the StepO-
nePlus™ cycler (Life Technologies). Relative expression
values were calculated with the ΔΔCT (analysis of rela-
tive gene expression) method [25] using ARF1 as the ref-
erence transcript. Primers used for CIN were 5′-
CTGGAGACCGACATCCTCTTT (forward) and 5′-
TTCTAGGCGGGAGACTCCTG (reverse), for ARF1 5′-
GACCACGATCCTCTACAAGC (forward) and 5′-
TCCCACACAGTGAAGCTGATG (reverse), for c-Myc
5′-TCGGATTCTCTGCTCTCCTC (forward) and 5′-
TCATCTTCTTGTTCCTCCTCAGA (reverse) for NES
5′-ATCGCTCAGGTCCTGGAA (forward) and 5′-
AAGCTGAGGGAAGTCTTGGA (reverse) and for
GFAP 5′-TGAAGCCGAAGAGTGGTACC (forward)
and 5′-GGTAGTCGTTGGCTTCGTG (reverse).
TUBB3 primers were described by others [26]. Analysis
of the CDKN2A deletion status was performed with four
different primer sets targeting the CDKN2A locus as has
been described by others [27, 28] with the real-time PCR
conditions as described above and primers for human
B2M as reference [29] as well as a commercially avail-
able human genomic DNA (Roche) as control.
Isolation of metabolites and measurement of active
vitamin B6 levels
Metabolites were isolated as has been described by
others [30] with the exception that we used DPBS sup-
plemented with 0.9% NaCl and 1% fraction V BSA for
quenching, which was performed at 4 °C. These changes
were necessary because extensive cell rupture occurred
without BSA and by incubation on ice. It should be
noted that vitamin B6 binds to BSA, albeit with lower af-
finity than to human serum albumin [31]. However, all
BSA containing media were carefully removed before
metabolite extraction and the amount of BSA used for
quenching and washing was identical for every cell line.
Therefore, the interference of BSA with the measured
vitamin B6 level is identical across samples. The extracts
were dried in a Savant SpeedVac-concentrator and fi-
nally resuspended in water to equal 20,000 cells/μl H2O.
Active vitamin B6 levels were measured with an enzym-
atic kit (Buehlmann Laboratories, Schoenenbuch,
Switzerland) according to the manufacturer’s instruc-
tions. The kit was validated to yield comparable results
to HPLC by the manufacturer and enzymatic methods
have been shown to yield comparable results to HPLC
in general [32]. Briefly, substrate was added to each well
of a 96-well plate and an equal volume of 1:40 diluted
sample was added. Afterwards, apoenzyme was added,
and the plate was shaken for 15 s at 400 rpm. The mix-
ture was incubated for 30 min at 37 °C, enzyme was
added and the plate was shaken for 15 s. Then, another
incubation was performed for 15 min. at 37 °C and the
OD546 was measured.
Bisulfite treatment and LINE-1 PCR
Bisulfite conversion of 1 μg genomic DNA was per-
formed with the EpiTect bisulfite kit (Qiagen, Hilden,
Germany) according to the manufacturer’s instructions.
Global DNA-methylation levels were estimated via
LINE-1 bisulfite PCR [33]. Amplification of LINE-1 ele-
ments was performed with HotStarTaq DNA polymerase
(initial denaturation at 95 °C for 15 min, 35 cycles of
94 °C for 90s, 50 °C for 60s, 72 °C for 60s and a final
elongation step at 72 °C for 10 min). Sequencing was
performed on a Pyromark Q24 instrument (Qiagen) fol-
lowing standard protocols.
Analysis of histone methylation
Cells were counted and ~ 1.5 × 105 cells were washed
and resuspended in DPBS containing 1% BSA, fixed
with 4% PFA for 15 min and collected by centrifugation
at 500 x g for 5 min. Afterwards, the cells were blocked
and permeabilized in DPBS supplemented with 0.5%
TritonX-100 and 5% normal goat serum (PAN Biotech).
After two washing steps with DPBS supplemented with
0.5% TritonX-100, the cells were stained with 1 μg
Histone-K27me3 antibody (rabbit polyclonal, Millipore,
Billerica, MA, USA) and a rabbit isotype control (rabbit
clone [DA1E], Cell Signalling Technologies) for 90 min.
in 100 μl DPBS supplemented with 0.5% TritonX-100
and 1% normal goat serum. Afterwards, cells were
washed twice, stained with a 1:200 diluted Alexa-Fluor
488 conjugated anti-rabbit secondary antibody (Thermo
Fisher Scientific) for 90 min, counterstained with
1 μg/ml DAPI for 10 min and washed again twice. Fi-
nally, the cells were resuspended in DPBS and ana-
lyzed on a BD FACS CantoII flow cytometer. Here,
DAPI positive single cells were gated and analyzed for
their fluorescence signal.
Colony formation assay
Colony formation was assessed with the reagents and
procedures as described previously [12] with the follow-
ing modifications. We increased the cell number to 3000
cells per well, but reduced the incubation time to two
weeks. For inhibitor treatment assays, Y-27632 was
added to the collagen solution as well as to the feeding
medium at the concentrations indicated. Water was used
as a control.
Library preparation for RNA-Seq
Libraries for next-generation sequencing were prepared
from 600 ng total RNA with the TrueSeq RNA library
preparation kit v2 as has been described previously [34].
Illumina deep sequencing was performed at a genomics
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core facility: Center of Excellence for Fluorescent Bioa-
nalytics (KFB, University of Regensburg, Germany) on a
HiSeq1000 instrument.
NGS data analysis
Analysis of NGS data was performed using the Genoma-
tix software (Genomatix, Munich, Germany). First, the
.fastq files were mapped to the human genome assembly
GRCh38 (annotation based on ElDorado 6–2015) using
the Genomatix Mining Station Mapper v3.7.6.3 allowing
one mismatch. All unique hits were further processed
using the Genomatix Genome Analyzer v3.51106 which
was used to create count tables for all samples. Reads
were counted locus-based, i.e. for unions of exons of
genes. All further analyzes were performed with the free
software R v3.1.1, Bioconductor v3.0 [35] and the pack-
age DESeq2 v1.6.3 [36]. Gene set enrichment analysis
[37] was performed with the ssGSEA module v7 [38]
with RPKM (reads per kilobase of exon model per mil-
lion mapped reads) values [39]. Subtype prediction was
performed with the ssGSEA module and the gene sets
proposed by ref. [40].
Data analysis
All analyzes were performed with GraphPad Prism 5.0
and R ver. 3.1.1. If not otherwise indicated, two-sided t-
tests were used for statistical analysis of two groups. For
three or more groups, a one-way ANOVA followed by
Dunnett’s multiple comparison test was applied. A result
was accepted as significant if p was < 0.05 and significant
differences were indicated where present (* p < 0.05, ** p
< 0.01 and *** p < 0.001). For the determination of IC50
values, the concentration of temozolomide used was log-
transformed, the fluorescence values were normalized
and a fit with variable slope was performed.
Results
Proteins regulating cofilin phosphorylation are strongly
downregulated in stem-like glioma cells
As a starting point, we performed an extensive molecu-
lar characterization of five non-adherent cell lines cul-
tured in serum-free medium and five adherent cell lines
cultured in serum-containing medium. For this purpose,
we determined their expression subtype by next gener-
ation sequencing followed by a single sample gene set
enrichment analysis. In addition, we determined
CDKN2A deletion, IDH1/2 mutation and the TP53 mu-
tational status of our cell lines (Fig. 1a and
Additional File 1: Table S1). We found that TP53 muta-
tions were very common alterations in both serum-
cultured and cell lines cultured under serum-free con-
ditions and that all lines tested carried at least a
hemizygous CDKN2A deletion (Fig. 1a). Interestingly,
the three best characterized glioblastoma expression
subtypes (proneural, classical, mesenchymal) were all
present in our cell line cohort (Fig. 1a). We also con-
firmed that the bona fide stem cell markers PROM1
(CD133), NES (nestin), SOX2 [41] as well as MYC (c-
Myc) were overexpressed in the cells cultured under
serum-free conditions (Fig. 1b), although the differ-
ence was only significant for PROM1 as determined
by DESeq2 (adj. p < 0.001). When we examined differ-
ential expression patterns between serum-cultured
cells and cells cultured in serum-free medium, we
found that proteins regulating cofilin phosphorylation
were indeed deregulated in stem-like cells, in a way
favoring lower cofilin phosphorylation (Fig. 1c). This
is in accordance with studies examining cofilin
phosphorylation in pluripotent cells and colon cancer
[9, 10, 42]. To corroborate these findings and exclud-
ing media artifacts, we reexamined the NGS-data
from another study [43] that established cultures from
tumor propagating glioma cells and differentiated gli-
oma cells. Indeed, we found similar effects (Fig. 1d).
Especially CIN was highly and significantly upregu-
lated in stem-like cells (p < 0.001, two-sided t-test,
Bonferroni-corrected). We then verified our sequen-
cing data with real-time PCR and western blotting.
There was a significant reduction in CIN mRNA as
judged by real-time PCR in serum-cultured lines
(two-sided Mann-Whitney test, p < 0.05) although
levels were variable (Fig. 1e). Normal human astro-
cytes were used as a reference for this analysis. CIN
showed a higher abundance on protein level in every
cell line cultured under serum-free conditions and the
difference in protein levels between the culture condi-
tions was highly significant (Fig. 1f, p < 0.0005).
We analyzed the levels of active vitamin B6 and ex-
pression changes in the pathway regulating vitamin B6
metabolism. Active vitamin B6 levels were significantly
higher in serum-cultured cell lines and the expression of
AOX1 that metabolizes the precursor of pyridoxal 5′-
phosphate, the active form of vitamin B6, was strongly
downregulated (Fig. 2a and b). We then examined cofilin
phosphorylation taking advantage of the PhosTag com-
pound [44], which separates specifically p-Ser3-cofilin
from unphosphorylated cofilin in glioma cells as estab-
lished previously [8]. We found that p-cofilin levels are
indeed strongly reduced in glioblastoma cell lines
cultured under non-adherent, serum-free conditions
(Fig. 2c and d; p < 0.01). Importantly, we also verified
this result with a p-Ser3-cofilin specific antibody and
found that results from PhosTag blotting and blotting
with a p-Ser3-cofilin specific antibody were highly corre-
lated (Additional file 2: Figure S1). We therefore hypoth-
esized that CIN might regulate glioblastoma stem cell
identity via its function in cofilin phosphorylation and/
or vitamin B6 metabolism.
Schulze et al. BMC Cancer  (2018) 18:524 Page 5 of 15
Fig. 1 CIN shows higher expression levels in non-adherent cells cultured under serum-free conditions than in adherent lines cultured in serum-
containing medium. a Molecular characteristics including expression subtype, presence of TP53 mutations and CDKN2A deletion of all cell lines
used in this study. Non-adherent cell lines cultured in serum-free medium show more often a proneural expression subtype, while mesenchymal
signatures are enriched in adherent, serum-cultured cell lines. Cell lines show high frequencies of TP53 mutations and CDKN2A deletions in both
conditions. A more comprehensive overview of molecular characteristics including expression patterns of key glioblastoma subtype genes can be
found in Additional file 1: Table S1. b DESeq2 analysis of stem cell markers in non-adherent cell lines cultured in serum-free medium vs. adherent,
serum-cultured cell lines. The stem cell marker PROM1 (CD133) is significantly overexpressed (DESeq2, adjusted p-value < 0.001). The stem cell
markers SOX2, c-MYC and NES show higher expression values in cells cultured in serum-free medium. However, the differences are not significant.
Shown are mean RPKM values + SD of n = 5 cell lines in each group. c DESeq2 analysis of genes regulating cofilin phosphorylation in cells cultured
in serum-free medium and serum-cultured cell lines. Chronophin (CIN/PDXP) is overexpressed in glioblastoma cells cultured in serum-free medium,
whereas LIMK1 is downregulated (DESeq2, adjusted p-value < 0.01 and p < 0.05, respectively). Shown is the log2 fold change of non-adherent cell lines
cultured in serum-free medium versus adherent, serum-cultured cell lines + standard error. d Analysis of the dataset GSE54791. Similar changes as in
(c) can be found in independently generated datasets of tumor propagating cells (TPC) and differentiated glioma cells (DGC). CIN is significantly
overexpressed in glioblastoma tumor propagating cells, while LIMK2 and ROCK1 are downregulated. The p-values shown are Bonferroni
corrected. e Analysis of CIN expression by real-time PCR. The expression of CIN is significantly higher (two-sided Mann-Whitney test, p <
0.05) in cells cultured in serum-free medium. Individual expression values of five non-adherent cell lines cultured in serum-free medium
vs. five adherent, serum-cultured cell lines are shown. The expression value in normal human astrocytes was set to one (red dotted line).
f Western blot analysis of CIN expression. The expression of CIN is high in all five cell lines cultured in serum-free medium and significantly higher
in these lines compared to the adherent, serum-cultured lines (two sided t-test, p = 0.0005)
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Cell proliferation is not perturbed by CIN loss in vitro
We established CIN-knockdown cell lines from two
stem-like cell lines representing the proneural expres-
sion subtype, NCH644 and NCH421k. CIN levels are
higher in this subtype as compared to the classical and
mesenchymal subtype in brain tumor samples [8] and
this model system should be closest to the tumor
situation.
There was a highly significant reduction in CIN
mRNA levels, but not in the mRNA levels of the stem
cell markers c-Myc or NES (two-way ANOVA,
Bonferroni-corrected post-test, p < 0.01 in NCH644 and
NCH421k for both CIN shRNA #1 and CIN shRNA
#2; p > 0.05 for c-Myc and NES, Fig. 3a and b). How-
ever, the differentiation markers GFAP and TUBB3
were overexpressed in every knockdown cell line
(Additional file 3: Figure S3). The CIN knockdown
was also confirmed on protein level in both NCH644
and NCH421k (Fig. 3c and d). Proliferation was nei-
ther affected in NCH421k nor NCH644 and knock-
down cell lines showed robust in vitro growth with
no differences to controls (repeated measures, two-
way ANOVA, Bonferroni-corrected post-hoc tests, p >
0.05; Fig. 3e and f ).
Active vitamin B6 levels are increased by CIN knockdown
We then analyzed if one of the two substrates of CIN,
active vitamin B6 or phosphocofilin showed altered
abundance after knockdown of CIN. Indeed, active vita-
min B6 levels increased significantly in NCH644 and
NCH421k cells (Fig. 4a and b: one-way ANOVA
followed by Dunnett’s multiple comparison’s test, p < 0.
05 and p < 0.001 for both shRNAs in NCH644 and
NCH421k, respectively), whereas phosphocofilin/total
cofilin ratios remained unaltered (Additional file 4: Fig-
ure S2, one-way ANOVA followed by Dunnett’s multiple
comparison’s test, p > 0.05). It should be noted that alter-
ations in phosphocofilin/total cofilin ratios are often ab-
sent in serum-cultured cell lines, too [8].
Impairment in colony formation capacity depends on
genetic background
We then examined if the highly clonogenic cell lines
NCH644 and NCH421k showed an alteration in colony
formation ability on CIN-knockdown. Indeed, the colony
numbers where significantly reduced by both CIN tar-
geting shRNAs in NCH644 (Fig. 4c, generalized linear
model, family = poisson, link-function = log, p < 0.01 for
both shRNAs) but not in NCH421k (Fig. 4d, generalized
Fig. 2 CIN substrates show higher abundance in adherent cell lines cultured in serum-containing medium than in non-adherent lines cultured in
serum-free medium. a DESeq2 analysis of non-adherent glioblastoma cells cultured in serum-free medium vs. adherent, serum-cultured cell lines.
AOX1, the enzyme that converts pyridoxal (the precursor of active pyridoxal 5′-phosphate) to 4-pyridoxate is strongly downregulated in cells cultured
in serum-free medium (DESeq2, adjusted p-value< 0.001). Shown is the log2FC + standard error. b Quantification of active vitamin B6 levels in (n = 5
each) serum-cultured lines and cells cultured in serum-free medium. Active vitamin B6 levels are significantly higher (two-sided Mann-Whitney test, p
< 0.01) in serum-cultured cell lines. c PhosTag western blot of glioblastoma cells grown under non-adherent, serum-free conditions and adherent,
serum-cultured cell lines probed with α-cofilin antibody. d Quantification of n = 5 serum-cultured cell lines and n = 5 cell lines grown in serum-free
medium. There is a significant increase (two-sided t-test, p < 0.01) in the p-cofilin/total cofilin ratio in serum-cultured cell lines
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linear model, family = poisson, link-function = log, p > 0.05
for both shRNAs). Importantly, treatment with the
ROCK-inhibitor Y-27632 led to a significant increase in
colony numbers (Fig. 4e, generalized linear model, family
= poisson, link-function = log, p < 0.01 for Y-27632 at
10 μM) supporting our hypothesis that phosphoregulation
of cofilin is responsible for this phenotype. In addition, in
NCH421k cells, no significant phenotype was found in
analogy to the CIN knockdown results.
Next generation sequencing reveals profound changes in
the cellular transcriptome after CIN downregulation
As cell proliferation itself was not perturbed by CIN
knockdown, we performed poly-A RNA-Seq in
NCH421k and NCH644 cells to determine if CIN might
influence stem cell-related transcriptional activity. We
deposited this dataset under GEO accession GSE98797.
On the single gene level, quality control plots showed a
high enrichment of small p-values after standard filtering
[36], indicative of a significant effect of CIN on the
cellular transcriptome and many deregulated genes
(Additional files 5, 6, 7: Figure S4, Table S2 and Table S3).
In NCH644, there were 409 upregulated and 258
downregulated genes and in NCH421k there were 172
upregulated and 66 downregulated genes (Fig. 5a and b:
logFC ≥0.6, adjusted p < 0.1). Hierarchical clustering
based on rlog normalized expression values of the
Top100 significantly deregulated genes (sorted by ad-
justed p-value) separated CIN shRNA and control cells
efficiently in both NCH644 (Fig. 5c) as well as NCH421k
(Fig. 5d). There was a limited overlap of 28 upregulated
and 8 downregulated genes, when NCH644 and
NCH421k were compared (Fig. 6a and b). Among the
common upregulated genes was the inhibitor of hedge-
hog signaling TULP3 [45], which was significantly over-
expressed in all CIN knockdown cell lines (Fig. 6c,
adjusted p-values calculated by DESeq2, · = p < 0.1, * = p
< 0.05, ** = p < 0.01, *** = p < 0.0001). The expression pat-
terns of other glioma stem cell promoting proteins that
were found in the list of deregulated genes, ITGA6 [46]
Fig. 3 Establishment of CIN knockdown cell lines and cell proliferation analyzes. a and b Real-time PCR of CIN, c-Myc and NES in NCH644 (a) and
NCH421k (b). While CIN levels are significantly reduced by two different CIN targeting shRNAs in NCH644 and NCH421k (p < 0.01), the mRNA
levels of the glioblastoma stem cell markers c-Myc and NES are not affected. c and d Representative examples of CIN western blots in NCH644 (c)
and NCH421k (d). The knockdown of CIN was efficient in both NCH644 and NCH421k. Alpha-tubulin was used as loading control. e and f
Proliferation assay of shRNA knockdown cell lines in NCH644 e and NCH421k f. There are no significant differences between control and
CIN shRNA cells (repeated measures two-way ANOVA followed by bonferroni corrected post-hoc tests)
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and BMI1 [47], where variable. While ITGA6 was sig-
nificantly downregulated in NCH421k there was only a
trend in NCH644 cells. BMI1, as well as other tumor
promoting genes (like EGFR and LEF1) were signifi-
cantly upregulated in NCH644 in contrast to our expec-
tations (Fig. 6d, adjusted p-values calculated by DESeq2,
· = p < 0.1, * = p < 0.05, ** = p < 0.01, *** = p < 0.0001).
CIN knockdown was highly efficient for both shRNAs in
both cell lines (Fig. 6e and f, adjusted p-values calculated
by DESeq2).
Global histone and DNA methylation, two possible
modifications linking the transcriptomic changes and
Fig. 4 Changes in cellular phenotypes after CIN knockdown. a and b Active vitamin B6 levels are significantly increased after CIN knockdown in
NCH644 a and NCH421k b (n = 3, one-way ANOVA followed by Dunnett’s multiple comparisons test, p < 0.05 and 0.001, respectively). Shown are
means + SD. c and d Colony formation assay in a collagen matrix. Colony numbers are significantly reduced after CIN knockdown in NCH644 (n = 3,
generalized linear model (poisson family with link function log), p < 0.01 for both CIN shRNAs) but not in NCH421k (d). Shown are means +SD. e and f
Colony formation assay in a collagen matrix. Colony numbers are significantly increased after treatment with 10 μM Y-27632 in NCH644 e (n = 3,
generalized linear model (poisson family with link function log), p < 0.01 for 10 μM Y-27632, p > 0.05 for 1 μM Y-27632) but not in NCH421k (f). Shown
are means +SD
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the cellular function of CIN, remained unaltered as de-
termined by flow cytometry and pyrosequencing of
LINE-1 elements (Additional file 8: Figure S5).
ROCK and LIMK inhibitors are non-toxic for glioma cells
and their influence on chemosensitivity is highly cell line-
dependent
Finally, as turnover of p-cofilin can be more important
than absolute levels of the phosphorylated protein and
altered absolute p-cofilin levels are not present in all cell
lines cultured in serum after CIN deregulation [8], we
tested if inhibitors of the upstream kinases ROCK1/2 or
LIMK1/2 are able to sensitize the cell lines NCH421k
and NCH644 to chemotherapeutic agents. Treatment
with these inhibitors alone had an effect -if any at
all- at excessively high concentrations (Fig. 7a and b,
Additional file 9: Figure S6, one-way ANOVA
followed by Dunnett’s multiple comparison test, sig-
nificant changes indicated). However, there were op-
posite effects in NCH644 and NCH421k: While after
inhibitor treatment of NCH644 cells there was a sig-
nificant chemosensitization towards temozolomide,
NCH421k cells instead showed an increase in resist-
ance to temozolomide (Fig. 7c-e, n = 3, one-way
ANOVA followed by Dunnett’s multiple comparisons
test, significant changes are indicated). Cofilin phos-
phorylation in our hands was very efficiently abol-
ished by 10 μM Y-27632 and LIMKi3 and less
efficiently by fasudil in stem-like cells. U87, a classical
serum cultured glioblastoma cell line with a very high
phosphocofilin level was used as a positive control
(Fig. 7f, Additional file 9: Figure S6). In contrast,
there was no change in chemosensitivity after CIN
knockdown (Additional file 10: Figure S7, one-way
ANOVA followed by Dunnett’s multiple comparison
test, significant changes indicated).
Discussion
It was previously shown that cell lines cultured in serum
in which CIN is targeted by a shRNA grow much slower
in vivo than their CIN expressing counterparts [8] sug-
gesting a loss of stemness in CIN deficient cells. Indeed,
we found that CIN is strongly overexpressed in glioblast-
oma cells cultured under serum-free, non-adherent con-
ditions which are thought to be permissive for stem-like
cells [12], in contrast to cell lines cultured in serum-
containing medium. It should be noted that, as we did
not compare genetically matched lines in different
media, effects of the genetic background on the pheno-
types cannot be entirely excluded. In addition, LIMK1
that catalyzes cofilin phosphorylation was downregulated
in cells grown under serum-free conditions in line with
reports that provide evidence for a stemness-promoting
role of unphosphorylated cofilin [9, 10]. The two canon-
ical cellular targets of CIN, pyridoxal 5′-phosphate [14],
the active form of vitamin B6, and p-Ser3-cofilin [11] are
strongly reduced in glioblastoma cells cultured in
serum-free medium. When modelling CIN loss in vitro,
Fig. 5 Next-generation sequencing based characterization of NCH644
and NCH421k CIN knockdown cells. a After CIN knockdown there are
409 upregulated and 258 downregulated genes in NCH644 CIN shRNA
cells as compared to CTRL cells. b After CIN knockdown there are 172
upregulated and 66 downregulated genes in NCH421k CIN shRNA
cells as compared to CTRL cells. c Heatmap of the Top100 differentially
regulated genes (sorted by adjusted p-value, based on rlog normalized
counts) in NCH644. Hierarchical clustering separates control cells and
knockdown cells efficiently. d Heatmap of the Top100 differentially
regulated genes (sorted by adjusted p-value, based on rlog normalized
counts) in NCH421k. Hierarchical clustering separates control cells and
knockdown cells efficiently
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we found an increase in active vitamin B6, a loss of col-
ony formation ability in one out of two cell lines but no
change in phosphocofilin levels. The latter might be ex-
plained by the fact that our cells grow as neurospheres
and that changes in phosphocofilin induced by CIN are
only induced in dependence on cell adhesion. In support
of our hypothesis, treatment with Y-27632, a ROCK-
inhibitor, induced the opposite phenotype with respect
to colony formation. In addition, alterations in the phos-
phocofilin/total cofilin ratio are often absent in serum-
cultured cell lines, too [8]. It should be noted that CIN
knockdown specifically promotes colony formation in
serum-cultured cells despite the loss of in vivo growth
capacity [8]. This finding underscores that cells cultured
under serum-free conditions and overexpressing the
stemness marker PROM1 -as utilized in our present in-
vestigation- better mimic the in vivo situation.
The observed changes in active vitamin B6 levels po-
tentially lead to global alterations in metabolism, as vita-
min B6 is a cofactor in numerous enzymatic reactions
[15]. A reduction in dietary vitamin B6 is used to reduce
global DNA-methylation in mice. Vitamin B6 is a
Fig. 6 Comparison of genes of interest between NCH644 and NCH421k. a and b Venn diagrams of the NCH644 and NCH421k dataset. There is a
limited overlap of 28 upregulated (a) and 8 downregulated (b) genes in both cell lines. c TULP3 is upregulated in both NCH644 and NCH421k
after CIN knockdown. P-values are calculated by DESeq2, shown are RPKM means + SD. d ITGA6 is significantly downregulated in NCH421k after
CIN knockdown, whereas BMI1 is upregulated in NCH644. P-values are calculated by DESeq2, shown are RPKM means + SD. (e) and (f) CIN is
significantly downregulated in the NGS dataset in both NCH644 (e) and NCH421k (f) (one-way ANOVA followed by Dunnett’s multiple
comparisons test, p < 0.001 for both shRNAs). Shown are means + SEM
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cofactor in SAM biosynthesis which is the main methyl
donor for DNA- and histone- methylation [48]. How-
ever, in our analyzes we did not observe any changes in
DNA- or histone-methylation, suggesting that vitamin
B6 is not a limiting factor for SAM biosynthesis in glio-
blastoma stem-like cells. There are several clues
suggesting an association between CIN and chemother-
apy resistance in glioblastoma cells: As such, stemness
and chemoresistance are supposed to be linked in glio-
blastoma [49], CIN regulates the actin cytoskeleton in
response to genotoxic stress [50] and vitamin B6 metab-
olism is an important factor for chemoresistance in lung
Fig. 7 Analysis of cell viability and chemosensitivity after ROCKi treatment. a and b Measurement of cell viability with resazurin in NCH644 (a) and
NCH421k (b) after Y-27632 treatment for 72 h. There is no significant decrease in cell viability after application of Y-27632 even at concentrations
up to 50 μM (n = 3, one-way ANOVA followed by Dunnett’s multiple comparisons test, p > 0.05). Shown are means + SEM. (c) and (d) Fit of dose
response curves to determine IC50 values with variable slope against the log transformed temozolomide concentration for NCH644 (c) and NCH421k
(d). e Quantification of dose response curves as shown in (c) and (d). Temozolomide chemosensitivity changes depend on cellular background. While
NCH644 cells are sensitized, NCH421k cells become more resistant by Y-27632 treatment (n = 3, one-way ANOVA followed by Dunnett’s multiple
comparisons test, significant changes are indicated). Shown are means + SD. f Western blot after PhosTag gel electrophoresis probed with
α-cofilin antibody. Inhibitor treatment with Y-27632 and LIMKi3 strongly reduces the levels of p-cofilin. Treatment with fasudil is less effective, especially
in stem-like cells
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cancer [21] that regulates cisplatin accumulation in vitro
[51]. Despite all those hints, the resistance to temozolo-
mide remained unaltered after CIN knockdown in both
cell lines examined. The lack of epigenetic vitamin B6
effects uncovered in this study may at least provide one
possible explanation for this phenomenon.
There were significant changes on the single gene level
after CIN knockdown, which are, however, difficult to
interpret with respect to stemness. While some stemness
promoting genes like EGFR, BMI1 and even LEF1 were
upregulated in NCH644, others like HES1 and HEY1
were downregulated, suggesting a complex relationship
between CIN effects on the regulation of stemness path-
ways and/or compensatory reactions within the cell
lines. One of the identified genes, TULP3, an inhibitor of
hedgehog signaling [52] caught our attention, as CIN
had been reported to be transcriptionally altered in re-
sponse to inhibition of hedgehog signaling in colon can-
cer cells [53]. Also, hedgehog pathway is important for
glioblastoma stem cell self-renewal [54]. We also noted
that besides TULP3, many other proteins that regulate
neuronal functions in health and disease, e.g. CAMK2B
[55], TTBK1 [56] and LRRN2 [57], were deregulated in
both cell lines suggesting a function of CIN in neuronal
development and (dys)function.
ROCK-inhibitors have been proposed to facilitate glio-
blastoma stem-like cell [23] and pluripotent stem cell
expansion [58]. Others have shown strong pro-apoptotic
action of LIMK-inhibitors in breast cancer cells [20] and
of ROCK-inhibitors on serum-cultured glioma cells [59].
Also, ROCK inhibitors have been suggested as effective
against leukemia [60]. In assessing the potential use of
these molecules in glioblastoma treatment we tested
their effectiveness in influencing cell viability of glio-
blastoma cells with or without the addition of alkylating
chemotherapeutics (temozolomide). ROCK- and LIMK-
inhibitors alone did not influence cell viability except at
excessive concentrations ≥25 μM. However, they were
well able to boost colony formation. In addition,
although we were able to show effective removal of p-
Ser3-cofilin in all cell lines, the responses towards che-
motherapeutic agents in presence of the inhibitors were
contrary between cell lines. Thus, use of these com-
pounds needs further clarification and a better under-
standing of the mechanism by which cofilin regulates
apoptosis.
Conclusion
Cofilin phosphorylation and Chronophin expression
differ between adherent cell lines cultured in serum-
containing medium and non-adherent glioblastoma
cell lines cultured in serum-free medium. Chronophin
knockdown in the latter setting induces phenotypic
changes, e.g. in colony formation and transcription,
but these are highly dependent on the cellular back-
ground. The same is true for phenotypes observed
after treatment with inhibitors for kinases regulating
cofilin phosphorylation, ROCKs and LIMKs. Targeting
the cofilin phosphorylation pathway might therefore
not be a straightforward therapeutic option in
glioblastoma.
Additional files
Additional file 1: Table S1. Comprehensive molecular characterization
of glioblastoma cell lines. Comprehensive molecular characterization of
all cell lines used in this study based on RNA-Seq. This table contains the
name of the cell lines, mutation and expression analysis for TP53, analysis
of genomic deletion (based on real-time PCR) and expression for
CDKN2A as well as expression data for several glioblastoma subtype-
specific genes. (XLSX 12 kb)
Additional file 2: Figure S1. P-Ser3-cofilin and cofilin western blotting.
(A) Western blots of lysates from non-adherent cells cultured in serum-
free medium and serum-cultured cell lines probed with α-Ser3-
phosphocofilin, α-cofilin and α-tubulin antibody. (B) Quantification of n =
5 cell lines in each group as shown in (A). There is a significant increase
(two-tailed t-test, p < 0.05) in the p-Ser3-cofilin signal relative to total cofilin
in serum-cultured cell lines. (C) Correlation analysis of standard western
blotting and PhosTag western blot. Quantifications from both
methods are highly correlated. (TIF 436 kb)
Additional file 3: Figure S2. Differentiation markers are induced upon
CIN depletion. (A) and (B) Real-time PCR of the differentiation markers
GFAP and TUBB3 in NCH644 (A) and NCH421k (B). There are significant
differences between the groups for GFAP and TUBB3 in NCH644 as well
as for GFAP in NCH421k (one-way anova, p < 0.05 for all comparisons
mentioned, n = 2). (TIF 294 kb)
Additional file 4: Figure S3. Analysis of phosphocofilin levels in CIN
knockdown cell lines. (A) Representative example of a western blot after
PhosTag gel electrophoresis probed with α-cofilin antibody. (B) and (C)
Quantification of western blots as shown in (A) for NCH644 (B) and
NCH421k (C). There is no significant difference in the P-cofilin/total cofilin
ratio between CTRL or CIN shRNA cells (n = 3, one-way ANOVA followed
by Dunnett’s multiple comparisons test, p > 0.05). Shown are means +
SD. (TIF 328 kb)
Additional file 5: Figure S4. Quality control plots for next generation
sequencing data. (A) and (C) There is a high enrichment of small p-values
after standard filtering in both NCH644 (A) and NCH421k (C) as calculated
by DESeq2. (B) and (D) MA-plots indicate the presence of many deregulated
genes (red) in both NCH644 (B) and NCH421k (D). (TIF 1008 kb)
Additional file 6: Table S2. Genes deregulated in NCH644 after CIN
knockdown (NGS results). Table of the results from the NGS analysis for
NCH644 (comparison CTRL vs. CIN shRNA #1 and #2) including statistics
as calculated by DESeq2. (XLSX 5446 kb)
Additional file 7: Table S3. Genes deregulated in NCH421k after CIN
knockdown (NGS results). Table of the results from the NGS analysis for
NCH421k (comparison CTRL vs. CIN shRNA #1 and #2) including statistics
as calculated by DESeq2. (XLSX 5355 kb)
Additional file 8: Figure S5. Flow cytometry-based analysis of histone
methylation levels and pyrosequencing-based analysis of global DNA
methylation. (A) Exemplary sequencing run of a LINE-1 sequence from
the Pyromark instrument. (B) Quantification of global DNA methylation
profiles by LINE-1 element pyrosequencing in NCH644 and NCH421k (n
= 3, one-way ANOVA followed by Dunnett’s multiple comparisons test,
p > 0.05). Shown are means + SD. (C) Quantification of flow cytometry
experiments of NCH644 cells stained with H3K27me3 or control IgG.
Levels of histone H3 trimethylated at lysine 27 remain unchanged after
CIN knockdown (n = 3, one-way ANOVA followed by Dunnett’s multiple
comparisons test, p > 0.05). Shown are geometric means + SD.
(TIF 893 kb)
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Additional file 9: Figure S6. Analysis of cell viability after LIMKi and
fasudil treatment. (A) and (B) Measurement of cell viability with resazurin
in NCH644 (A) and NCH421k (B) after LIMKi3 inhibitor treatment for 72 h.
There is no significant decrease in cell viability after LIMKi3 application
even at concentrations up to 50 μM (n = 3, one-way ANOVA followed by
Dunnett’s multiple comparisons test, p > 0.05). Shown are means + SEM.
(C) and (D) Measurement of cell viability with resazurin in NCH644 (C)
and NCH421k (D) after fasudil treatment. A significant decrease in cell
viability occurred only in NCH421k at the highest concentrations of 25
and 50 μM (n = 3, one-way ANOVA followed by Dunnett’s multiple
comparisons test, p < 0.01 and 0.001, respectively). Shown are means + SEM.
(E) Western blot after PhosTag gel electrophoresis probed with α-cofilin
antibody. Inhibitor treatment with LIMKi3 strongly reduces the levels of
p-cofilin. (TIF 1192 kb)
Additional file 10: Figure S7. Analysis of chemosensitivity in CIN
knockdown cell lines. Temozolomide chemosensitivity remains unaltered
after CIN knockdown. In both NCH644 and NCH421k there is no
significant difference in IC50 values after CIN knockdown (n = 3, one-way
ANOVA followed by Dunnett’s multiple comparisons test, p > 0.05).
Shown are means + SD. (TIF 256 kb)
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